Vimian Group AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0015961982
SEK
29.94
1.14 (3.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROCE of 7.21%

  • The company has been able to generate a Return on Capital Employed (avg) of 7.21% signifying low profitability per unit of total capital (equity and debt)
2

High Debt Company with a Debt to Equity ratio (avg) at times

3

Healthy long term growth as Net Sales has grown by an annual rate of 81.43% and Operating profit at 80.15%

4

With ROE of 5.06%, it has a fair valuation with a 2.01 Price to Book Value

5

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

SEK 16,273 Million (Small Cap)

stock-summary
P/E

40.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.30

stock-summary
Return on Equity

5.97%

stock-summary
Price to Book

2.15

Revenue and Profits:
Net Sales:
1,143 Million
(Quarterly Results - Jun 2025)
Net Profit:
94 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.99%
0%
-0.99%
6 Months
-28.88%
0%
-28.88%
1 Year
-32.87%
0%
-32.87%
2 Years
17.66%
0%
17.66%
3 Years
-9.43%
0%
-9.43%
4 Years
-50.84%
0%
-50.84%
5 Years
0%
0%
0.0%

Vimian Group AB for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
81.43%
EBIT Growth (5y)
80.15%
EBIT to Interest (avg)
3.45
Debt to EBITDA (avg)
2.40
Net Debt to Equity (avg)
0.22
Sales to Capital Employed (avg)
0.41
Tax Ratio
35.21%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.21%
ROE (avg)
3.39%
Valuation key factors
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
2.01
EV to EBIT
23.00
EV to EBITDA
15.22
EV to Capital Employed
1.77
EV to Sales
3.90
PEG Ratio
0.41
Dividend Yield
NA
ROCE (Latest)
7.70%
ROE (Latest)
5.06%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -5.35% vs 0.15% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 78.41% vs -63.31% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,143.00",
          "val2": "1,207.60",
          "chgp": "-5.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "274.00",
          "val2": "361.70",
          "chgp": "-24.25%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "17.50",
          "val2": "84.30",
          "chgp": "-79.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-11.00",
          "val2": "-79.80",
          "chgp": "86.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "94.20",
          "val2": "52.80",
          "chgp": "78.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "154.40%",
          "val2": "215.80%",
          "chgp": "-6.14%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 12.58% vs 27.25% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 83.46% vs 257.05% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,286.40",
          "val2": "3,807.30",
          "chgp": "12.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,075.00",
          "val2": "963.50",
          "chgp": "11.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "290.50",
          "val2": "221.00",
          "chgp": "31.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-99.50",
          "val2": "-100.70",
          "chgp": "1.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "220.70",
          "val2": "120.30",
          "chgp": "83.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "160.90%",
          "val2": "156.50%",
          "chgp": "0.44%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
1,143.00
1,207.60
-5.35%
Operating Profit (PBDIT) excl Other Income
274.00
361.70
-24.25%
Interest
17.50
84.30
-79.24%
Exceptional Items
-11.00
-79.80
86.22%
Consolidate Net Profit
94.20
52.80
78.41%
Operating Profit Margin (Excl OI)
154.40%
215.80%
-6.14%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -5.35% vs 0.15% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 78.41% vs -63.31% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
4,286.40
3,807.30
12.58%
Operating Profit (PBDIT) excl Other Income
1,075.00
963.50
11.57%
Interest
290.50
221.00
31.45%
Exceptional Items
-99.50
-100.70
1.19%
Consolidate Net Profit
220.70
120.30
83.46%
Operating Profit Margin (Excl OI)
160.90%
156.50%
0.44%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 12.58% vs 27.25% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 83.46% vs 257.05% in Dec 2023

stock-summaryCompany CV
About Vimian Group AB stock-summary
stock-summary
Vimian Group AB
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available